Cargando…
Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma
BACKGROUND: We aimed to screen a specific secretory protein that could serve as blood diagnostic marker for cholangiocarcinoma (CCA). METHODS: Starting with the analysis of gene expression profiles in tumor tissues and matched normal tissues from cases with CCA and hepatocellular carcinoma (HCC), we...
Autores principales: | Jiang, Yong, Zheng, Xiaohu, Jiao, Defeng, Chen, Peng, Xu, Yechuan, Wei, Haiming, Qian, Yeben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414306/ https://www.ncbi.nlm.nih.gov/pubmed/30638862 http://dx.doi.org/10.1016/j.ebiom.2018.12.063 |
Ejemplares similares
-
Talin-1 interaction network promotes hepatocellular carcinoma progression
por: Chen, Peng, et al.
Publicado: (2017) -
Immune infiltrating cells in cholangiocarcinoma may become clinical diagnostic markers: based on bioinformatics analysis
por: Zhang, Yongwei, et al.
Publicado: (2021) -
Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity
por: Prusty, Bhupesh K., et al.
Publicado: (2018) -
Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
por: Wang, Dongyao, et al.
Publicado: (2019) -
Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)
por: ZENG, XIAOJUN, et al.
Publicado: (2015)